Bristol-Myers Squibb Co. (BMY) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.85 +1.81%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
